CLINICAL TRIALS PROFILE FOR OLANZAPINE PAMOATE
✉ Email this page to a colleague
All Clinical Trials for OLANZAPINE PAMOATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00320489 ↗ | Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia | Completed | Eli Lilly and Company | Phase 3 | 2006-04-01 | To compare the health outcome of patients with schizophrenia, who are at risk for relapse, when treated with a long acting injection form of olanzapine versus treatment with oral olanzapine. |
NCT01389908 ↗ | A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder | Unknown status | Shalvata Mental Health Center | N/A | 2011-06-01 | The purpose of this study is to assess the long-term efficacy of Olanzapine Pamoate (OP) Depot in patients diagnosed with schizophrenia or schizoaffective disorder. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OLANZAPINE PAMOATE
Condition Name
Clinical Trial Locations for OLANZAPINE PAMOATE
Trials by Country
Clinical Trial Progress for OLANZAPINE PAMOATE
Clinical Trial Phase
Clinical Trial Sponsors for OLANZAPINE PAMOATE
Sponsor Name